Click for best price
Postpemic Era LongActing Injectables Market Size, Share 2022
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
Beijing Yanjing Bizhi Information Consulting Co., Ltd. ?XYZResearch?released the ?Post-pandemic Era-Global Long-Acting Injectables Market Analysis 2022, With Top Companies, Sales, Revenue, Consumption, Price and Growth Rate?, which aims to sort out the development status and trends of the Long-Acting Injectables industry at home and abroad, estimate the overall market scale of the Long-Acting Injectables industry and the market share of major countries, Long-Acting Injectables industry, and study and judge the downstream market demand of Long-Acting Injectables through systematic research, Analyze the competition pattern of Long-Acting Injectables, so as to help solve the pain points of various stakeholders in Long-Acting Injectables industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018- 2028) of Long-Acting Injectables Market by XYZResearch Include
NorthAmerica
Asia
Europe
Middle East & Africa
South America
Competitive Analysis; Who are the Major Players in Long-Acting Injectables Market?
Eli Lilly
Pfizer
GlaxoSmithKline
Johnson & Johnson
Lupin
Zogenix
DURECT
Medincel
Major Type of Long-Acting Injectables Covered in XYZResearch report:
Small and Middle Sized Molecule
Large Sized Molecule
Application Segments Covered in XYZResearch Market
Schizophrenia
Other Psychotic Disorders
For any other requirements, please feel free to contact us and we will provide you customized report.
| Report Attributes |
Report Details |
| Report Title |
Post-pandemic Era-Global Long-Acting Injectables Market Analysis 2022, With Top Companies, Sales, Revenue, Consumption, Price and Growth Rate |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
83 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
Table of Contents
Post-pandemic Era-Global Long-Acting Injectables Market Analysis 2022, With Top Companies, Sales, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Small and Middle Sized Molecule -Product Introduction and Major Company
1.1.2 Large Sized Molecule -Product Introduction and Major Company
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Five-Year Compound Annual Growth Rate (CAGR)
2 Regional Market
2.1 Regional Market Share in Terms of Sales (2018 & 2022 & 2026)
2.2 Regional Market Share in Terms of Revenue (2018 & 2022 & 2026)
2.3 Regional Market Share in Terms of Consumption (2018 & 2022 & 2026)
3 Global Long-Acting Injectables Market Assessment by Type
3.1 Global Long-Acting Injectables Sales by Type (2018-2028)
3.2 Global Long-Acting Injectables Revenue by Type (2018-2028)
3.3 North America Long-Acting Injectables Sales and Revenue by Type (2018-2028)
3.4 Asia Long-Acting Injectables Sales and Revenue by Type (2018-2028)
3.5 Europe Long-Acting Injectables Sales and Revenue by Type (2018-2028)
3.6 Middle East & Africa Long-Acting Injectables Sales and Revenue by Type (2018-2028)
3.7 South America Long-Acting Injectables Sales and Revenue by Type (2018-2028)
4 Historical & Forecast Global Long-Acting Injectables Market Assessment by Application
4.1 Global Long-Acting Injectables Consumption and Consumption in Different Application Field (2018-2028)
4.2 North America Long-Acting Injectables Consumption and Consumption in Different Application Field (2018-2028)
4.3 Asia Long-Acting Injectables Consumption and Consumption in Different Application Field (2018-2028)
4.4 Europe Long-Acting Injectables Consumption and Consumption in Different Application Field (2018-2028)
4.5 Middle East & Africa Long-Acting Injectables Consumption and Consumption in Different Application Field (2018-2028)
4.6 South America Long-Acting Injectables Consumption and Consumption in Different Application Field (2018-2028)
5 North America
5.1 US Long-Acting Injectables Sales, Revenue and Growth Rate (2018-2028)
5.2 Canada Long-Acting Injectables Sales, Revenue and Growth Rate (2018-2028)
5.3 Mexico Long-Acting Injectables Sales, Revenue and Growth Rate (2018-2028)
6 Asia
6.1 China Long-Acting Injectables Sales, Revenue and Growth Rate (2018-2028)
6.2 Japan Long-Acting Injectables Sales, Revenue and Growth Rate (2018-2028)
6.3 India Long-Acting Injectables Sales, Revenue and Growth Rate (2018-2028)
6.4 Korea Long-Acting Injectables Sales, Revenue and Growth Rate (2018-2028)
6.5 Southeat Asia Long-Acting Injectables Sales, Revenue and Growth Rate (2018-2028)
7 Europe
7.1 Germany Long-Acting Injectables Sales, Revenue and Growth Rate (2018-2028)
7.2 UK Long-Acting Injectables Sales, Revenue and Growth Rate (2018-2028)
7.3 France Long-Acting Injectables Sales, Revenue and Growth Rate (2018-2028)
7.4 Russia Long-Acting Injectables Sales, Revenue and Growth Rate (2018-2028)
7.5 Italy Long-Acting Injectables Sales, Revenue and Growth Rate (2018-2028)
8 Middle East and Africa
8.1 Saudi Long-Acting Injectables Sales, Revenue and Growth Rate (2018-2028)
8.2 UAE Long-Acting Injectables Sales, Revenue and Growth Rate (2018-2028)
8.3 Egypt Long-Acting Injectables Sales, Revenue and Growth Rate (2018-2028)
8.4 Nigeria Long-Acting Injectables Sales, Revenue and Growth Rate (2018-2028)
8.5 South Africa Long-Acting Injectables Sales, Revenue and Growth Rate (2018-2028)
9 South America
9.1 Brazil Long-Acting Injectables Sales, Revenue and Growth Rate (2018-2028)
9.2 Argentina Long-Acting Injectables Sales, Revenue and Growth Rate (2018-2028)
9.3 Colombia Long-Acting Injectables Sales, Revenue and Growth Rate (2018-2028)
10 Global Long-Acting Injectables Average Price Trend
10.1 Market Price for Each Type of Long-Acting Injectables in North America (2018-2028)
10.2 Market Price for Each Type of Long-Acting Injectables in Asia (2018-2028)
10.3 Market Price for Each Type of Long-Acting Injectables in Europe (2018-2028)
10.4 Market Price for Each Type of Long-Acting Injectables in Middle East & Africa (2018-2028)
10.5 Market Price for Each Type of Long-Acting Injectables in South America (2018-2028)
11 Value Chain
11.1 Long-Acting Injectables Value Chain Analysis
11.1.1 Upstream
11.1.2 Downstream
11.2 COVID-19 Impact on Long-Acting Injectables Industry
11.2.1 Industrial Policy Issued Under the Epidemic Situation
11.2.2 Post-pandemic Era
11.3 Cost-Under the Epidemic Situation
11.3.1 Cost of Raw Material
11.4 Channel Analysis
11.4.1 Distribution Channel-Under the Epidemic Situation
11.4.2 Distributors
12 Major Players of Global Long-Acting Injectables Market, Competitive Analysis
12.1 Eli Lilly
12.1.1 Eli Lilly Company Profiles and Company News
12.1.2 Eli Lilly Product Introduction
12.1.3 Eli Lilly Long-Acting Injectables Sales, Revenue (2018-2022)
12.1.4 SWOT Analysis
12.2 Pfizer
12.2.1 Pfizer Company Profiles and Company News
12.2.2 Pfizer Product Introduction
12.2.3 Pfizer Long-Acting Injectables Sales, Revenue (2018-2022)
12.2.4 SWOT Analysis
12.3 GlaxoSmithKline
12.3.1 GlaxoSmithKline Company Profiles and Company News
12.3.2 GlaxoSmithKline Product Introduction
12.3.3 GlaxoSmithKline Long-Acting Injectables Sales, Revenue (2018-2022)
12.3.4 SWOT Analysis
12.4 Johnson & Johnson
12.4.1 Johnson & Johnson Company Profiles and Company News
12.4.2 Johnson & Johnson Product Introduction
12.4.3 Johnson & Johnson Long-Acting Injectables Sales, Revenue (2018-2022)
12.4.4 SWOT Analysis
12.5.1 Lupin Company Profiles and Company News
12.5.2 Lupin Product Introduction
12.5.3 Lupin Long-Acting Injectables Sales, Revenue (2018-2022)
12.5.4 SWOT Analysis
12.6 Zogenix
12.6.1 Zogenix Company Profiles and Company News
12.6.2 Zogenix Product Introduction
12.6.3 Zogenix Long-Acting Injectables Sales, Revenue (2018-2022)
12.6.4 SWOT Analysis
12.7 DURECT
12.7.1 DURECT Company Profiles and Company News
12.7.2 DURECT Product Introduction
12.7.3 DURECT Long-Acting Injectables Sales, Revenue (2018-2022)
12.7.4 SWOT Analysis
12.8 Medincel
12.8.1 Medincel Company Profiles and Company News
12.8.2 Medincel Product Introduction
12.8.3 Medincel Long-Acting Injectables Sales, Revenue (2018-2022)
12.8.4 SWOT Analysis
13 Global Long-Acting Injectables Market, Competitive Landscape and Market Forecast
13.1 Key Companies Dominating the Global Long-Acting Injectables Market
13.2 Concentration Ratio (CR5) of Global Long-Acting Injectables Market (2018)
13.2.1 Market Share of Top 5 Players in Term of Revenue (2018)
13.3 Concentration Ratio (CR5) of Global Long-Acting Injectables Market (2022)
13.3.1 Market Share of Top 5 Players in Term of Revenue (2022)
14 Conclusion
15 Methodology and Data Source
LIST OF TABLES & FIGURES
List of Tables and Figures
Figure Product Introduction
Table Sales (K Units) and Revenue (Million USD) of Major Players (2018-2022)
Figure Global Long-Acting Injectables Sales Market Share of Top 5 Players
Table CAGR of Major Market (2021-2026)
Table CAGR in Terms of Sales of Each Type (2018-2028)
Table Regional Market Share in Terms of Sales (2019-2026)
Figure Regional Market Share in Terms of Sales (2019 - 2020)
Table Regional Market Share in Terms of Revenue (2019-2026)
Figure Regional Market Share in Terms of Revenue (2019 - 2020)
Figure Regional Market Share in Terms of Consumption (2019 - 2020)
Figure Regional Market Share in Terms of Consumption (2019 - 2020)
Table Global Long-Acting Injectables Sales (K Unit) by Type (2018-2028)
Figure Global Long-Acting Injectables Sales (K Unit) and Growth Rate (2018-2028)
Figure Global Long-Acting Injectables Sales Market Share (%) by Type (2019 -2020)
Table Global Long-Acting Injectables Revenue (Million USD) by Type (2018-2028)
Figure Global Long-Acting Injectables Revenue (Million USD) and Growth Rate (2018-2028)
Figure Global Long-Acting Injectables Revenue Market Share (%) by Type (2019-2020)
Figure North America Long-Acting Injectables Sales (K Unit) by Type (2018-2028)
Figure North America Long-Acting Injectables Sales (K Unit) and Growth Rate (2018-2028)
Figure North America Long-Acting Injectables Revenue (Million USD) by Type (2018-2028)
Figure North America Long-Acting Injectables Revenue (Million USD) and Growth Rate (2018-2028)
Figure Asia Long-Acting Injectables Sales (K Unit) by Type (2018-2028)
Figure Asia Long-Acting Injectables Sales (K Unit) and Growth Rate (2018-2028)
Figure Asia Long-Acting Injectables Revenue (Million USD) by Type (2018-2028)
Figure Asia Long-Acting Injectables Revenue (Million USD) and Growth Rate (2018-2028)
Figure Europe Long-Acting Injectables Sales (K Unit) by Type (2018-2028)
Figure Europe Long-Acting Injectables Sales (K Unit) and Growth Rate (2018-2028)
Figure Europe Long-Acting Injectables Revenue (Million USD) by Type (2018-2028)
Figure Europe Long-Acting Injectables Revenue (Million USD) and Growth Rate (2018-2028)
Figure Middle East & Africa Long-Acting Injectables Sales (K Unit) by Type (2018-2028)
Figure Middle East & Africa Long-Acting Injectables Sales (K Unit) and Growth Rate (2018-2028)
Figure Middle East & Africa Long-Acting Injectables Revenue (Million USD) by Type (2018-2028)
Figure Middle East & Africa Long-Acting Injectables Revenue (Million USD) and Growth Rate (2018-2028)
Figure South America Long-Acting Injectables Sales (K Unit) by Type (2018-2028)
Figure South America Long-Acting Injectables Sales (K Unit) and Growth Rate (2018-2028)
Figure South America Long-Acting Injectables Revenue (Million USD) by Type (2018-2028)
Figure South America Long-Acting Injectables Revenue (Million USD) and Growth Rate (2018-2028)
Table Historical & Forecast Long-Acting Injectables Different Application Field Consumption (K Unit)
Figure Consumption (K Unit) and Growth Rate (2018-2028)
Figure Different Application Field Consumption Market Share (%) (2019-2020)
Table Historical & Forecast Long-Acting Injectables Different Application Field Consumption (K Unit)
Figure North America Long-Acting Injectables Consumption (K Unit) and Growth Rate (2018-2028)
Figure North America Long-Acting Injectables Consumption Market Share (%) by Application (2018-2028)
Table Historical & Forecast Long-Acting Injectables Different Application Field Consumption (K Unit)
Figure Asia Long-Acting Injectables Consumption (K Unit) and Growth Rate (2018-2028)
Figure Asia Long-Acting Injectables Consumption Market Share (%) by Application (2018-2028)
Table Historical & Forecast Long-Acting Injectables Different Application Field Consumption (K Unit)
Figure Europe Long-Acting Injectables Consumption (K Unit) and Growth Rate (2018-2028)
Figure Europe Long-Acting Injectables Consumption Market Share (%) by Application (2018-2028)
Table Historical & Forecast Long-Acting Injectables Different Application Field Consumption (K Unit)
Figure Middle East & Africa Long-Acting Injectables Consumption (K Unit) and Growth Rate (2018-2028)
Figure Middle East & Africa Long-Acting Injectables Consumption Market Share (%) by Application (2018-2028)
Table Historical & Forecast Long-Acting Injectables Different Application Field Consumption (K Unit)
Figure South America Long-Acting Injectables Consumption (K Unit) and Growth Rate (2018-2028)
Figure South America Long-Acting Injectables Consumption Market Share (%) by Application (2018-2028)
Table Historical & Forecast Long-Acting Injectables Different Application Field Consumption (K Unit)
Table US Long-Acting Injectables Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Canada Long-Acting Injectables Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Mexico Long-Acting Injectables Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table China Long-Acting Injectables Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Japan Long-Acting Injectables Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table India Long-Acting Injectables Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Korea Long-Acting Injectables Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Southeast Asia Long-Acting Injectables Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Germany Long-Acting Injectables Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table UK Long-Acting Injectables Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table France Long-Acting Injectables Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Russia Long-Acting Injectables Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Italy Long-Acting Injectables Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Saudi Long-Acting Injectables Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table UAE Long-Acting Injectables Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Egypt Long-Acting Injectables Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Nigeria Long-Acting Injectables Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table South Africa Long-Acting Injectables Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Brazil Long-Acting Injectables Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Argentina Long-Acting Injectables Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Colombia Long-Acting Injectables Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Market Price (USD/Unit) for Each Type of Long-Acting Injectables in China
Table Market Price (USD/Unit) for Each Type of Long-Acting Injectables in EU
Table Market Price (USD/Unit) for Each Type of Long-Acting Injectables in USA
Table Market Price (USD/Unit) for Each Type of Long-Acting Injectables in Japan
Table Market Price (USD/Unit) for Each Type of Long-Acting Injectables in India
Table Market Price (USD/Unit) for Each Type of Long-Acting Injectables in Southeast Asia
Table Market Price (USD/Unit) for Each Type of Long-Acting Injectables in South America
Figure Value Chain Structure of Long-Acting Injectables
Table Value Chain
Table Key Suppliers of Raw Material/Components
Table Key Downstream Customer in Each Application Field
Table Industry News List of Long-Acting Injectables
Figure Cost Structure of Long-Acting Injectables in 2020
Table Distributors/Traders List
Table Eli Lilly Profiles
Table Eli Lilly Long-Acting Injectables Product Introduction
Figure Eli Lilly Long-Acting Injectables Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Eli Lilly SWOT Analysis
Table Pfizer Profiles
Table Pfizer Long-Acting Injectables Product Introduction
Figure Pfizer Long-Acting Injectables Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Pfizer SWOT Analysis
Table GlaxoSmithKline Profiles
Table GlaxoSmithKline Long-Acting Injectables Product Introduction
Figure GlaxoSmithKline Long-Acting Injectables Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure GlaxoSmithKline SWOT Analysis
Table Johnson & Johnson Profiles
Table Johnson & Johnson Long-Acting Injectables Product Introduction
Figure Johnson & Johnson Long-Acting Injectables Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Johnson & Johnson SWOT Analysis
Table Lupin Profiles
Table Lupin Long-Acting Injectables Product Introduction
Figure Lupin Medical Devices & Consumables Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Lupin SWOT Analysis
Table Zogenix Profiles
Table Zogenix Long-Acting Injectables Product Introduction
Figure Zogenix Long-Acting Injectables Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Zogenix SWOT Analysis
Table DURECT Profiles
Table DURECT Long-Acting Injectables Product Introduction
Figure DURECT Long-Acting Injectables Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure DURECT SWOT Analysis
Table Medincel Profiles
Table Medincel Long-Acting Injectables Product Introduction
Figure Medincel Long-Acting Injectables Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Medincel SWOT Analysis
